|
Real-time
Oslo Bors
14:45:06 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 13.40 NOK | 0.00% |
|
+4.28% | -43.70% |
| 10-20 | Navamedic Extends Nordic Rights for Mysimba Obesity Drug | MT |
| 10-20 | Navamedic ASA Extends Mysimba Distribution Agreement With Azurity Pharmaceuticals | CI |
| Market Cap | 321M 34.5M 30.85M 28.54M 25.84M 48.37M 3.28B 49.16M 343M 136M 1.72B 129M 127M 5.44B | P/E 2026 * |
-38.7x | P/E 2027 * | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 439M 47.14M 42.16M 39M 35.31M 66.09M 4.49B 67.17M 469M 186M 2.35B 177M 173M 7.43B | EV / Sales 2026 * |
0.78x | EV / Sales 2027 * | 0.7x |
| Free-Float |
30.5% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| NAVA | Real-time | |
CBOE
| NAVAo | Real-time | |
|
CBOE
| 0FDB | Real-time | |
|
Deutsche Boerse AG
| N1A | Delayed | |
|
Börse Stuttgart
| N1A | Delayed |
Last Transcript: Navamedic ASA
| 1 week | +4.28% | ||
| Current month | -2.55% | ||
| 1 month | +0.75% | ||
| 3 months | -17.54% | ||
| 6 months | -31.28% | ||
| Current year | -43.70% |
| 1 week | 12.7 |  | 13.4 |
| 1 month | 12.5 | | 13.9 |
| Current year | 12.5 | | 24.5 |
| 1 year | 12.5 | | 26.5 |
| 3 years | 12.5 | | 41.9 |
| 5 years | 12.5 | | 43.9 |
| 10 years | 8.5 | | 43.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lars Minor
CEO | Chief Executive Officer | 55 | 18/06/2026 |
| Director of Finance/CFO | - | 01/01/2026 | |
Annika Palo
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Morten Jurs
CHM | Chairman | 66 | - |
Rune Wahl
BRD | Director/Board Member | 60 | 01/06/2024 |
Hilde Furberg
BRD | Director/Board Member | 68 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/12/24 | Buy | Chief Operating Officer | 10,267 | 0.0581% | ||
| 09/09/24 | Exercice | Chief Executive Officer | 80,000 | 0.4589% | ||
| 09/09/24 | Exercice | Chief Operating Officer | 75,000 | 0.4302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.28% | -43.22% | -64.74% | 34.5M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,140B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 641B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 507B | |
| -0.08% | +1.69% | +48.28% | +66.77% | 383B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 347B | |
| +0.85% | +1.42% | +24.37% | +53.18% | 293B | |
| -0.27% | +1.62% | +2.20% | +26.65% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 240B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 197B | |
| Average | +0.26% | +2.67% | +29.65% | +58.34% | 401.38B | |
| Weighted average by Cap. | +0.22% | +2.98% | +41.68% | +84.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 566M 60.82M 54.38M 50.31M 45.55M 85.26M 5.79B 86.66M 605M 239M 3.03B 228M 223M 9.58B | 598M 64.21M 57.41M 53.12M 48.09M 90.01M 6.11B 91.49M 639M 253M 3.19B 241M 236M 10.12B |
| Net income | -8.5M -913K -816K -755K -684K -1.28M -86.83M -1.3M -9.09M -3.59M -45.41M -3.43M -3.35M -144M | 11.5M 1.23M 1.1M 1.02M 925K 1.73M 117M 1.76M 12.29M 4.86M 61.44M 4.63M 4.54M 195M |
| Net Debt | 118M 12.64M 11.3M 10.46M 9.47M 17.72M 1.2B 18.01M 126M 49.78M 629M 47.44M 46.43M 1.99B | 95.77M 10.28M 9.19M 8.51M 7.7M 14.41M 978M 14.65M 102M 40.49M 512M 38.59M 37.77M 1.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | NOK 13.40 | 0.00% | 3,163 |
| 26/10/26 | NOK 13.40 | +0.75% | 15,585 |
| 23/10/26 | NOK 13.30 | +4.72% | 4,236 |
| 22/10/26 | NOK 12.70 | -2.31% | 23,667 |
| 21/10/26 | NOK 13.00 | +1.17% | 69,013 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAVA Stock
Select your edition
All financial news and data tailored to specific country editions
